| Operating Activities | |
| Net loss | |
| Adjustments to reconcile net loss to net cash provided by operating activities | |
| Depreciation | 3.07M |
| Impairment of property, plant and equipment | 0 |
| Non-cash compensation cost | 466K |
| Deferred income taxes | -94K |
| Other, net | -12K |
| Changes in operating assets and liabilities: | |
| Trade accounts receivable, net | -806K |
| Prepaid expenses and other assets | -1.14M |
| Accounts payable | -359K |
| Income taxes, net | 85K |
| Accrued and other liabilities | 965K |
| Net cash provided by operating activities | |
| Investing Activities | |
| Proceeds from disposition of investments available for sale | |
| Proceeds from note receivable | 165K |
| Purchases of property, plant and equipment | -1.12M |
| Net cash used in investing activities | |
| Financing Activities | |
| Principal payments on line of credit | -913K |
| Proceeds from line of credit | 913K |
| Proceeds from issuance of common stock | 33K |
| Principal payments on capital lease obligations | -12K |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | 9.18M |
| Cash and cash equivalents at end of period | 7.34M |
| Supplemental Disclosure of Cash Flow Information | |
| Cash paid for interest | |
| Income taxes paid | |